Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Cells and Secretions of the Pancreas

Cells and Secretions of the Pancreas

The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Chronic Pancreatitis II: Pathophysiology

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dysosmobacter welbionis J115T reduces stress-like phenotype in high-fat diet-induced obese female mice.

Beneficial microbes·2025

Same author

Gender-associated differences in oral microbiota and salivary biochemical parameters in response to feeding.

Journal of physiology and biochemistry·2020

Same author

Elevated high density lipoprotein cholesterol and low grade systemic inflammation is associated with increased gut permeability in normoglycemic men.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018

Same author

Interactions between gut microbes and host cells control gut barrier and metabolism.

International journal of obesity supplements·2017

Same author

Maternal undernutrition programs the apelinergic system of adipose tissue in adult male rat offspring.

Journal of developmental origins of health and disease·2017

Same author

Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2016

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Published on: June 2, 2018

Pancreatic alpha-cell dysfunction in diabetes.

R Burcelin¹, C Knauf, P D Cani

¹Institute of Molecular Medicine, team Functional genomic of metabolic diseases, Rangueil hospital, 1, av Prof Jean Poulhes, 31403 Toulouse Cedex, France. burcelin@toulouse.inserm.fr

Diabetes & Metabolism

|July 22, 2008

Summary

This summary is machine-generated.

Dysregulated glucagon secretion contributes to high blood sugar in type 2 diabetes. Targeting glucagon regulation, particularly with GLP-1, offers promising therapeutic strategies for better diabetes management and preventing hypoglycemia.

More Related Videos

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation

Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation

Published on: August 7, 2015

Related Experiment Videos

Last Updated: Jul 3, 2026

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Published on: June 2, 2018

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation

Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation

Published on: August 7, 2015

Area of Science:

Endocrinology
Metabolic Disorders
Molecular Biology

Background:

Type 2 diabetes is characterized by excessive hepatic glucose production and insulin resistance, leading to hyperglycemia.
Increased and unregulated plasma glucagon concentration is a key feature in type 2 diabetes.
Understanding glucagon secretion is crucial for treating type 2 diabetes and managing counterregulatory hormone imbalances.

Purpose of the Study:

To investigate the physiological regulation of glucagon secretion.
To understand the impairment of glucagon secretion in diabetes.
To explore therapeutic strategies targeting glucagon regulation.

Main Methods:

Review of physiological and molecular mechanisms of glucagon secretion.
Analysis of glucose detection pathways in alpha-cells.
Examination of the role of GLUT2, K-ATP channels, CNS, and GLP-1.

Main Results:

Glucagon secretion is an immediate response to glucopenia, regulated by mechanisms similar to insulin secretion.
Molecular pathways involving GLUT2, K-ATP channels, and GLP-1 are implicated in glucose-regulated glucagon secretion.
Incretins like GLP-1 show promise in normalizing plasma glucagon in type 2 diabetes.

Conclusions:

Restoring glucose-regulated glucagon secretion is a vital therapeutic goal for type 2 diabetes.
GLP-1's action on glucose sensors may explain its benefit in normalizing glucagon levels.
Targeting glucagon secretion mechanisms can help prevent iatrogenic hypoglycemia in diabetic patients.